Phase I epithelial lining study of ceftolozane/tazobactam.
Phase of Trial: Phase I
Latest Information Update: 06 Jul 2012
At a glance
- Drugs Ceftolozane/tazobactam (Primary) ; Piperacillin/tazobactam (Primary)
- Indications Gram-negative infections; Nosocomial pneumonia; Pseudomonal infections; Respiratory tract infections
- Focus Pharmacodynamics; Pharmacokinetics
- 23 Oct 2011 Results presented at the 49th Annual Meeting of the Infectious Diseases Society of America.
- 16 Jun 2011 Status changed from recruiting to completed based on information reported in a Cubist Pharmaceuticals media release.
- 16 Jun 2011 Results have been reported in a Cubist Pharmaceuticals media release.